Salu KJ - Search Results

1

Drug-eluting stents: a new treatment in the prevention of restenosis. Part II: Clinical studies.

Salu KJ, Bosmans JM, Bult H, Vrints CJ. Salu KJ, et al. Acta Cardiol. 2004 Apr;59(2):165-77 contd. doi: 10.2143/AC.59.2.2005172. Acta Cardiol. 2004. PMID: 15139658 Review. No abstract available.

2

Drug-eluting stents: a new treatment in the prevention of restenosis. Part I: Experimental studies.

Salu KJ, Bosmans JM, Bult H, Vrints CJ. Salu KJ, et al. Acta Cardiol. 2004 Feb;59(1):51-61. doi: 10.2143/AC.59.1.2005159. Acta Cardiol. 2004. PMID: 15030135 Review. No abstract available.

3

A three-dimensional quantitative analysis of restenosis parameters after balloon angioplasty: comparison between semi-automatic computer-assisted planimetry and stereology.

Salu KJ, Knaapen MW, Bosmans JM, Vrints CJ, Bult H. Salu KJ, et al. J Vasc Res. 2002 Sep-Oct;39(5):437-46. doi: 10.1159/000064514. J Vasc Res. 2002. PMID: 12297706

4

Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model.

Salu KJ, Huang Y, Bosmans JM, Liu X, Li S, Wang L, Verbeken E, Bult H, Vrints CJ, De Scheerder IK. Salu KJ, et al. Coron Artery Dis. 2003 Dec;14(8):545-55. doi: 10.1097/00019501-200312000-00005. Coron Artery Dis. 2003. PMID: 14646676

5

Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.

Salu KJ, Bosmans JM, Huang Y, Hendriks M, Verhoeven M, Levels A, Cooper S, De Scheerder IK, Vrints CJ, Bult H. Salu KJ, et al. Cardiovasc Res. 2006 Feb 1;69(2):536-44. doi: 10.1016/j.cardiores.2005.11.012. Epub 2005 Dec 28. Cardiovasc Res. 2006. PMID: 16386237

6

Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.

Huang Y, Salu K, Wang L, Liu X, Li S, Lorenz G, Wnendt S, Verbeken E, Bosmans J, Van de Werf F, De Scheerder I. Huang Y, et al. J Invasive Cardiol. 2005 Mar;17(3):142-8. J Invasive Cardiol. 2005. PMID: 15867441

7

Stent-mediated methylprednisolone delivery reduces macrophage contents and in-stent neointimal formation.

Wang L, Salu K, Verbeken E, Bosmans J, Van de Werf F, De Scheerder I, Huang Y. Wang L, et al. Coron Artery Dis. 2005 Jun;16(4):237-43. doi: 10.1097/00019501-200506000-00005. Coron Artery Dis. 2005. PMID: 15915076

8

Methotrexate loaded SAE coated coronary stents reduce neointimal hyperplasia in a porcine coronary model.

Huang Y, Salu K, Liu X, Li S, Wang L, Verbeken E, Bosmans J, De Scheerder I. Huang Y, et al. Heart. 2004 Feb;90(2):195-9. doi: 10.1136/hrt.2002.008169. Heart. 2004. PMID: 14729797 Free PMC article.

9

Selective clearance of macrophages in atherosclerotic plaques by autophagy.

Verheye S, Martinet W, Kockx MM, Knaapen MW, Salu K, Timmermans JP, Ellis JT, Kilpatrick DL, De Meyer GR. Verheye S, et al. J Am Coll Cardiol. 2007 Feb 13;49(6):706-15. doi: 10.1016/j.jacc.2006.09.047. Epub 2007 Jan 26. J Am Coll Cardiol. 2007. PMID: 17291937 Free article.

10

Histopathologic evaluation of a novel-design nitinol stent: the Biflex stent.

Verheye S, De Meyer G, Salu K, Knaapen M, Kockx M. Verheye S, et al. Int J Cardiovasc Intervent. 2004;6(1):13-9. doi: 10.1080/14628840410030342. Int J Cardiovasc Intervent. 2004. PMID: 15204168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters